TrialMedicine2016

The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients With Bipolar II Disorder.

Ting-Ting Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.